Detalles de la búsqueda
1.
A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
J Antimicrob Chemother
; 62 Suppl 1: i29-40, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18684704
Resultados
1 -
1
de 1
1
Próxima >
>>